0001104659-20-038882.txt : 20200326 0001104659-20-038882.hdr.sgml : 20200326 20200326170220 ACCESSION NUMBER: 0001104659-20-038882 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200324 FILED AS OF DATE: 20200326 DATE AS OF CHANGE: 20200326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHADE CHRISTIAN S CENTRAL INDEX KEY: 0001214496 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 20746809 MAIL ADDRESS: STREET 1: MEDAREX STREET 2: 707 STATE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6095104718 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 a4.xml 4 X0306 4 2020-03-24 0 0001781983 Aprea Therapeutics, Inc. APRE 0001214496 SCHADE CHRISTIAN S 535 BOYLSTON STREET BOSTON MA 02116 1 1 0 0 President & CEO Stock Option (right to Buy) 35.50 2020-03-24 4 A 0 127000 0 A 2030-03-24 Common Stock 127000 127000 D Twenty-five percent of these options vest on March 24, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions. /s/ Scott M. Coiante, attorney-in-fact 2020-03-26